AIFF fireflyneuro.com Net earnings per share (EPS TTM)
Firefly Neuroscience, Inc (AIFF) reports a TTM fundamental earnings per share metric of -0.49, driven by management's expertise in scaling the BNA AI platform. Growth is based on US IT infrastructure for brain monitoring and rising demand for neurodiagnostics. Business stability is supported by a neutral geopolitical backdrop and the medical status of the technologies, which creates a safe operating environment for the company.
Analytical breakdowns for Firefly Neuro (AIFF)
- stock price and consensus target price:
- market capitalization data:
- business book valuation details:
- debt and solvency information:
Total Debt to Equity Ratio Firefly Neuroscience, Inc|AIFF - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Firefly Neuroscience|AIFF - Company Aggregate Debt|Debts to Book Capitalization Firefly Neuroscience, Inc.|AIFF - Long-Term Debt|Company Current Liabilities Firefly Neuroscience|Quick Liquidity fireflyneuro.com
- earnings and multiples data:
AIFF - Final Profit|Expected Profit Firefly Neuroscience, Inc|AIFF - Market Cap to Earnings|Future Price to Earnings Firefly Neuro|AIFF - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple AIFF|AIFF - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Firefly Neuroscience|AIFF - Net earnings per share for the last four quarters|Quarterly EPS earnings growth fireflyneuro.com|AIFF - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Firefly Neuroscience, Inc
- sales and revenue indicators:
Fundamental valuation:Firefly Neuro (AIFF)
The development of AI diagnostics at Firefly Neuroscience, Inc (AIFF) is reflected in the dynamics of the trailing twelve months (TTM) net income per share. This metric determines the portion of profit attributable to a single security over the last twelve months. The calculation is based on dividing the final annual financial result by the total number of shares outstanding. The stable medical status of the business minimizes geopolitical risks, making this indicator a transparent tool for assessing efficiency. An analysis of the chart's extremes warns investors against overpaying when purchasing the asset at its peak.
Main competitors
biogen.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (Neurocrine)|RGC: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Axsome Therapeutics Inc|ACAD (ACADIA Corp) - Net earnings per share (EPS TTM)|XENE: Earnings per share for the trailing year|Net earnings per share for the last 12 months VKTX (Viking Therapeutics, Inc.)|Net earnings per share (EPS TTM) Supernus Pharmaceuticals, Inc. (SUPN)|Catalyst Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters DNLI (Denali Therapeutics Inc)|Harmony Biosciences - Net earnings per share (EPS TTM)|Earnings per share for the trailing year BHVN (biohavenpharma.com)|AMLX: Net earnings per share (EPS TTM)|Trevi Therapeutics, Inc. - Earnings per share for the trailing year|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year
